The expression of NRP1 across all cancers and controls in TCGA datasets was plotted using UALCAN, where high and significant expression between normal and tumor was seen in glioblastoma, kidney cancer, and pancreatic cancer; the details are presented in Figure 10A. The expression of NRP1 in control and the GBM, pancreatic cancers, and renal cancers was plotted using a box plot in GEPIA2, where we observed that in tumor conditions, there is a higher expression of NRP1 than in controls. This evidence concerns the gene NRP1 and renal carcinoma.